Company intelligence / Profile preview

Augmenticon

Glattbrugg/Zürich, Zurich, Switzerlandaugmenticon.ch ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Augmenticon develops and commercializes augmented reality/mixed reality (AR/MR) and Industry 4.0 digital tools to optimize radiopharmaceutical operations, focusing on fully remote-controlled GMP-compliant manufacturing guidance, control, and documentation. Their MES/QMS/LIMS support services are tailored for pharmaceutical production environments with a strong focus on radiopharmaceuticals.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

oculavis (technology/service integration)Qualio (QMS/MES/LIMS implementation partner)

Beyond the preview

Go deeper on Augmenticon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Augmenticon.

Explore the full profile